Elevated cholesterol levels and systemic inflammation are considered relevant risk factors for cardiovascular disease (CVD) development and progression. Increasing evidence suggests that cholesterol-lowering and inflammation-lowering nutraceuticals are useful in the management of moderate hypercholesterolemia. Here, we describe the study protocol of a clinical trial aimed to evaluate the cholesterol and inflammatory lowering effect of an innovative dietary supplement (BruMeChol™, Mivell S.r.l., Italy), composed of a mixture of extracts of bergamot and olive fruits in association with vitamin K2 in subjects with mild hypercholesterolemia
High HDL-cholesterol (HDL-C) values are negatively correlated with cardiovascular diseases. This rev...
Nutritional approaches to improve dyslipidemias have been recently developed, but evidences on diffe...
none6noBackground: There is an increasing interest for combined nutraceuticals that can act on sever...
Elevated cholesterol levels and systemic inflammation are considered relevant risk factors for cardi...
none5noOur double-blind, placebo-controlled, parallel-group, dose-escalation, clinical trial aimed t...
Background: Cholesterol-lowering nutraceuticals are useful in the management of moderate hypercholes...
Background: Some patients experience statin-induced side effects or prefer nutraceutical approaches ...
none2noCardiovascular diseases (CVDs) are one of the major causes of mortality and disability in Wes...
Introduction: There is growing interest in lipid-lowering nutraceuticals; however, there are a relat...
This study was aimed at evaluating the tolerability of a nutraceutical combination with anticholeste...
: Cardiovascular diseases (CVDs) are the main cause of mortality worldwide. Risk factors of CVD can ...
AbstractBackgroundhyperlipidemia is one of the most important cardiovascular risk factors. Statins a...
This is a double-blind, placebo-controlled clinical trial on a combined nutraceutical non containing...
UNLABELLED:A dietary supplement (AP, Armolipid Plus) that combines red yeast rice extract, policosan...
AIM: Evidence showed that LDL-cholesterol lowering is associated with a significant cardiovascular ...
High HDL-cholesterol (HDL-C) values are negatively correlated with cardiovascular diseases. This rev...
Nutritional approaches to improve dyslipidemias have been recently developed, but evidences on diffe...
none6noBackground: There is an increasing interest for combined nutraceuticals that can act on sever...
Elevated cholesterol levels and systemic inflammation are considered relevant risk factors for cardi...
none5noOur double-blind, placebo-controlled, parallel-group, dose-escalation, clinical trial aimed t...
Background: Cholesterol-lowering nutraceuticals are useful in the management of moderate hypercholes...
Background: Some patients experience statin-induced side effects or prefer nutraceutical approaches ...
none2noCardiovascular diseases (CVDs) are one of the major causes of mortality and disability in Wes...
Introduction: There is growing interest in lipid-lowering nutraceuticals; however, there are a relat...
This study was aimed at evaluating the tolerability of a nutraceutical combination with anticholeste...
: Cardiovascular diseases (CVDs) are the main cause of mortality worldwide. Risk factors of CVD can ...
AbstractBackgroundhyperlipidemia is one of the most important cardiovascular risk factors. Statins a...
This is a double-blind, placebo-controlled clinical trial on a combined nutraceutical non containing...
UNLABELLED:A dietary supplement (AP, Armolipid Plus) that combines red yeast rice extract, policosan...
AIM: Evidence showed that LDL-cholesterol lowering is associated with a significant cardiovascular ...
High HDL-cholesterol (HDL-C) values are negatively correlated with cardiovascular diseases. This rev...
Nutritional approaches to improve dyslipidemias have been recently developed, but evidences on diffe...
none6noBackground: There is an increasing interest for combined nutraceuticals that can act on sever...